Injectable ibuprofen-loaded liposome–hydrogel microspheres as nano/microplex for tendinopathy therapy
Source abstract
Abstract
Tendinopathy is characterized by persistent inflammation, matrix disruption, and impaired regeneration. Current clinical treatments have difficulty achieving sustained local retention and controlled release of anti-inflammatory drugs within the pathological environment. To address this challenge, this study developed a hierarchical “nano-microplex” delivery system. First, liposomes (lipo) loaded with the hydrophobic anti-inflammatory drug ibuprofen (ibu) and surface-grafted with a collagen-binding peptide (CBP) were prepared using thin-film dispersion. Then, monodisperse, injectable, size-controlled hyaluronic acid methacrylate (HAMA) hydrogel microspheres (MS) were fabricated using microfluidics and UV crosslinking to efficiently encapsulate the liposomes. These microspheres provide a hydrophilic microenvironment and a local, sustained-release reservoir. CBP confers affinity for collagen-rich extracellular matrices (ECM), enhancing local retention within tendons. Finally, sustained ibu release suppresses inflammation while promoting ECM remodeling and tendon functional recovery. In animal models of tendinopathy, this system exhibited sustained local therapeutic effects and significant efficacy. This study establishes a scalable, injectable nano-microplex delivery strategy for mechanically active soft tissues, such as those affected by tendinopathy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Tendon Structure and Treatment · Hydrogels: synthesis, properties, applications · Advancements in Transdermal Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. The pathogenesis of tendinopathy: balancing the response to loading10.1038/nrrheum.2010.43 ↗
2. Achilles tendinopathy10.1038/s41572-025-00602-9 ↗
3. Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy10.1080/15548627.2023.2249392 ↗
4. Peptic ulcer disease: a review10.1001/jama.2024.19094 ↗
5. An injectable liposome-anchored teriparatide incorporated gallic acid-grafted gelatin hydrogel for osteoarthritis treatment10.1038/s41467-023-38597-0 ↗
6. Osteophilic and dual-regulated alendronate-gene lipoplexes for reversing bone loss
7. Liposome-based interventions in knee osteoarthritis10.1002/smll.202410060 ↗
8. Lymphatic-draining nanoparticles deliver Bay K8644 payload to lymphatic vessels and enhance their pumping function10.1126/sciadv.abq0435 ↗
9. Urease-powered nanobots for radionuclide bladder cancer therapy10.1038/s41565-023-01577-y ↗
10. A cuproptosis nanocapsule for cancer radiotherapy10.1038/s41565-024-01784-1 ↗
11. Injectable amphipathic artesunate prodrug-hydrogel microsphere as gene/drug nano-microplex for rheumatoid arthritis therapy
12. Advanced hydrogel material for meniscus repair
13. Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity10.1038/s41392-021-00830-x ↗
14. Injectable hybrid hydrogels enhance macrophage communication via second messenger amplification10.1016/j.jconrel.2026.114610 ↗
15. Hydrogel microspheres empowering Organ-on-a-Chip systems: innovations and applications10.1002/smll.71144 ↗
16. Du · 2022 · vol 2022 · 3
17. Precise cell type electrical stimulation therapy via force-electric hydrogel microspheres for cartilage healing
18. Boosting mRNA-Engineered monocytes via prodrug-like microspheres for bone microenvironment multi-phase remodeling
19. In situ remodeling of efferocytosis via lesion-localized microspheres to reverse cartilage senescence10.1002/advs.202400345 ↗
20. An mRNA microsphere vaccine inhibiting overactivation of DNA sensing mechanisms10.1016/j.scib.2025.11.016 ↗
21. Intelligent vascularized 3D/4D/5D/6D-Printed tissue scaffolds10.1007/s40820-023-01187-2 ↗
22. Biomimetic injectable hydrogel microspheres with enhanced lubrication and controllable drug release for the treatment of osteoarthritis
23. The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNA10.1016/j.jconrel.2024.08.016 ↗
24. Silencing gene-engineered injectable hydrogel microsphere for regulation of extracellular matrix metabolism balance
25. Injectable microgels with hybrid exosomes of chondrocyte-targeted FGF18 gene-editing and self-renewable lubrication for osteoarthritis therapy
26. Boosting ribosomal translation via ionizable lipid-hydrogel microplexes for localized mRNA therapy
27. Collagen-binding peptides for the enhanced imaging, lubrication and regeneration of osteoarthritic articular cartilage10.1038/s41551-022-00948-5 ↗
28. Microfluidic tissue engineering and bio-actuation
29. Thioether phosphatidylcholine liposomes: a novel ROS-responsive platform for drug delivery10.1021/acsami.9b08901 ↗
30. Regulating chondro-bone metabolism for treatment of osteoarthritis via high-permeability micro/nano hydrogel microspheres
31. Programming ordered tissue reconstruction via artificial bionic tendon sheath for tendinopathy treatment
32. Biomimetic “Tendon Band-Aid” regulates inflammatory microenvironment and tenogenic differentiation for tendinopathy regeneration10.1186/s12951-025-03956-0 ↗
33. Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery10.1016/j.jconrel.2023.07.031 ↗
34. Cell-specific mRNA delivery via nanobody-functionalized lipid nanoparticles10.1016/j.jconrel.2025.114365 ↗
35. Microparticles, microcapsules and microspheres: a review of recent developments and prospects for oral delivery of insulin10.1016/j.ijpharm.2017.12.036 ↗